Literature DB >> 11123062

The role of cytokines, chemokines, and adhesion molecules in the pathogenesis of idiopathic inflammatory myopathies.

I E Lundberg1.   

Abstract

Cytokines, chemokines, and adhesion molecules are important mediators in chronic inflammation and in immune regulation. In idiopathic inflammatory myopathies (IIM), increased expression of proinflammatory cytokines particularly interleukin (IL)-1alpha and IL-1beta, tumor necrosis factor (TNF)-alpha and macrophage inflammatory proteins (MIP)-1alpha, as well as of the inhibitory cytokines transforming growth factor (TGF)-beta was observed in muscle. There was no difference in cytokine and chemokine pattern between polymyositis, dermatomyositis, and inclusion body myositis, which could indicate that similar pathogenetic mechanisms are involved in these subsets of myositis. A prominent finding of IL-1alpha expression in endothelial cells, both in patients with active inflammation and in patients with chronic persisting muscle weakness without inflammation, makes this an interesting molecule in understanding the mechanisms for the pathogenesis of muscle weakness. Involvement of the blood vessels in the pathogenesis of myositis was further supported by increased expression of adhesion molecules and by a phenotypical expression of endothelial cells, resembling high endothelium venules in all three subsets of IIM. The molecular studies to date indicate a role of the microvessels in the pathogenesis of IIM not only in DM, as was previously suggested, but also in PM and IBM. The studies also indicate that IL-1alpha could be a target molecule for new therapeutical interventions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11123062     DOI: 10.1007/s11926-000-0082-y

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  59 in total

Review 1.  Polymyositis, dermatomyositis and inclusion-body myositis.

Authors:  M C Dalakas
Journal:  N Engl J Med       Date:  1991-11-21       Impact factor: 91.245

2.  Pulsed intravenous methylprednisolone therapy for inflammatory myopathies: evaluation of the effect by comparing two consecutive biopsies from the same muscle.

Authors:  S Matsubara; S Hirai; Y Sawa
Journal:  J Neuroimmunol       Date:  1997-06       Impact factor: 3.478

3.  Costimulatory markers in muscle of patients with idiopathic inflammatory myopathies and in cultured muscle cells.

Authors:  K Nagaraju; N Raben; M L Villalba; C Danning; L A Loeffler; E Lee; N Tresser; A Abati; P Fetsch; P H Plotz
Journal:  Clin Immunol       Date:  1999-08       Impact factor: 3.969

4.  Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies.

Authors:  A M Emslie-Smith; K Arahata; A G Engel
Journal:  Hum Pathol       Date:  1989-03       Impact factor: 3.466

5.  Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies.

Authors:  I Lundberg; A K Ulfgren; P Nyberg; U Andersson; L Klareskog
Journal:  Arthritis Rheum       Date:  1997-05

6.  Magnetic resonance imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositis.

Authors:  J H Park; T L Vital; N M Ryder; M Hernanz-Schulman; C L Partain; R R Price; N J Olsen
Journal:  Arthritis Rheum       Date:  1994-05

7.  Inclusion body myositis: explanation for poor response to immunosuppressive therapy.

Authors:  R J Barohn; A A Amato; Z Sahenk; J T Kissel; J R Mendell
Journal:  Neurology       Date:  1995-07       Impact factor: 9.910

8.  IL-1 alpha induced, TNF alpha mediated HLA class II (DR) antigen up-regulation in a human ductal breast carcinoma cell line ZR-75-1.

Authors:  P Speiser; R Zeillinger; C Wiltschke; J Sedlák; B Chorváth
Journal:  Neoplasma       Date:  1993       Impact factor: 2.575

9.  MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies.

Authors:  E Bartoccioni; S Gallucci; F Scuderi; E Ricci; S Servidei; A Broccolini; P Tonali
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

10.  Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls.

Authors:  I Lundberg; J M Brengman; A G Engel
Journal:  J Neuroimmunol       Date:  1995-12       Impact factor: 3.478

View more
  24 in total

1.  Expression of calcium-binding proteins MRP8 and MRP14 in inflammatory muscle diseases.

Authors:  Stephan Seeliger; Thomas Vogl; Ingo Hubert Engels; J Michael Schröder; Clemens Sorg; Cord Sunderkötter; Johannes Roth
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

Review 2.  Clinical manifestations and pathogenesis of hydroxyapatite crystal deposition in juvenile dermatomyositis.

Authors:  Lauren M Pachman; Adele L Boskey
Journal:  Curr Rheumatol Rep       Date:  2006-06       Impact factor: 4.592

3.  Anti-inflammatory effects of glyceollins derived from soybean by elicitation with Aspergillus sojae.

Authors:  Hyo Jung Kim; Mi-Kyung Sung; Jong-Sang Kim
Journal:  Inflamm Res       Date:  2011-06-14       Impact factor: 4.575

4.  Alternative splicing factor ASF/SF2 is down regulated in inflamed muscle.

Authors:  Z Xiong; A Shaibani; Y-P Li; Y Yan; S Zhang; Y Yang; F Yang; H Wang; X-F Yang
Journal:  J Clin Pathol       Date:  2006-03-30       Impact factor: 3.411

5.  The clinical utility of serum IL-35 in patients with polymyositis and dermatomyositis.

Authors:  Liguo Yin; Yongpeng Ge; Hanbo Yang; Qinglin Peng; Xin Lu; Yamei Zhang; Guochun Wang
Journal:  Clin Rheumatol       Date:  2016-08-08       Impact factor: 2.980

6.  Anti-inflammatory effects of ethanol extract from Kummerowia striata (Thunb.) Schindl on lps-stimulated RAW 264.7 cell.

Authors:  Jun-Yan Tao; Lei Zhao; Zhi-Jun Huang; Xiao-Yu Zhang; Shu-Ling Zhang; Qiong-Guang Zhang; Bao-Hui Zhang; Qi-Lin Feng; Guo-Hua Zheng
Journal:  Inflammation       Date:  2008-04-22       Impact factor: 4.092

7.  Oxidant-induced atrogin-1 and transforming growth factor-beta1 precede alcohol-related myopathy in rats.

Authors:  Jeffrey S Otis; Lou Ann S Brown; David M Guidot
Journal:  Muscle Nerve       Date:  2007-12       Impact factor: 3.217

Review 8.  Idiopathic inflammatory myopathies: a treatment update.

Authors:  Chester V Oddis
Journal:  Curr Rheumatol Rep       Date:  2003-12       Impact factor: 4.592

9.  Cytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis.

Authors:  Gulnara Mamyrova; Terrance P O'Hanlon; Laura Sillers; Karen Malley; Laura James-Newton; Christina G Parks; Glinda S Cooper; Janardan P Pandey; Frederick W Miller; Lisa G Rider
Journal:  Arthritis Rheum       Date:  2008-12

Review 10.  Toll-like receptors and damage-associated molecular patterns: novel links between inflammation and hypertension.

Authors:  Cameron G McCarthy; Styliani Goulopoulou; Camilla F Wenceslau; Kathryn Spitler; Takayuki Matsumoto; R Clinton Webb
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-10-25       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.